RT Journal Article
SR Electronic
T1 On the timing of interventions to preserve hospital capacity: lessons to be learned from the Belgian SARS-CoV-2 pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.18.20248450
DO 10.1101/2020.12.18.20248450
A1 Niel Hens
A1 Christel Faes
A1 Marius Gilbert
YR 2020
UL http://medrxiv.org/content/early/2020/12/19/2020.12.18.20248450.abstract
AB Using publicly available data on the number of new hospitalisations we use a newly developed phase portrait to monitor the epidemic allowing for assessing whether or not intervention measures are needed to keep hospital capacity under control. Using this phase portrait, we show that intervention measures were effective in mitigating a Summer resurgence but that too little too late was done to prevent a large autumn wave in Belgium.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNH and CF acknowledge support from the European Union's Horizon 2020 research and innovation programme - project EpiPose (Grant agreement number 101003688) and NH acknowledges support from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement 682540 - TransMID). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No ethical approval was necessary.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used in this manuscript has been made available by Sciensano. https://epistat.wiv-isp.be/covid/